Peptidomimetic blockade of MYB in acute myeloid leukemia
MYB activity is a key factor for the maintenance of acute myeloid leukemias but it is also a difficult target. Here, the authors develop a peptidomimetic (MYBMIM) that prevents the interaction of the trans-activation domain of MYB with the KIX domain of CBP/P300 and inhibits leukaemia growth.
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Portfolio
2018-01-01
|
| Serier: | Nature Communications |
| Online adgang: | https://doi.org/10.1038/s41467-017-02618-6 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
